BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26528699)

  • 1. The Complexity of Pain Management in Patients with Erythromelalgia.
    Patel N; Chen E; Cucchiaro G
    A A Case Rep; 2015 Nov; 5(9):151-3. PubMed ID: 26528699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment.
    Nathan A; Rose JB; Guite JW; Hehir D; Milovcich K
    Pediatrics; 2005 Apr; 115(4):e504-7. PubMed ID: 15741349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off.
    Choi JS; Zhang L; Dib-Hajj SD; Han C; Tyrrell L; Lin Z; Wang X; Yang Y; Waxman SG
    Exp Neurol; 2009 Apr; 216(2):383-9. PubMed ID: 19162012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromelagia: a rare and hard-to-treat condition: a 9-year-old boy responsive to intravenous lidocaine and oral mexilitene.
    Elgueta F; de la Cuadra-Fontaine JC; Clede L; Fierro C; Valderrama A
    Pain Med; 2013 Feb; 14(2):311-2. PubMed ID: 23368881
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory erythromelalgia of the ears: response to mexiletine.
    Vivas AC; Escandon J; Kirsner RS
    Am J Otolaryngol; 2011; 32(2):168-70. PubMed ID: 20392536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalamic stimulation as a treatment for primary erythromelalgia: technical case report.
    Delye H; Lagae L; Vermylen J; Nuttin B
    Neurosurgery; 2005 Oct; 57(4 Suppl):E404; discussion E404. PubMed ID: 16234658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with oral mexiletine in primary erythromelalgia in children.
    Iqbal J; Bhat MI; Charoo BA; Syed WA; Sheikh MA; Bhat IN
    Ann Saudi Med; 2009; 29(4):316-8. PubMed ID: 19584578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute monophasic erythromelalgia pain in five children diagnosed as small-fiber neuropathy.
    Faignart N; Nguyen K; Soroken C; Poloni C; Downs HM; Laubscher B; Korff C; Oaklander AL; Roulet Perez E
    Eur J Paediatr Neurol; 2020 Sep; 28():198-204. PubMed ID: 32723684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
    Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
    Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of intractable pain in erythromelalgia by using spinal cord stimulation.
    Graziotti PJ; Goucke CR
    J Pain Symptom Manage; 1993 Oct; 8(7):502-4. PubMed ID: 7963776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of primary erythromelalgia successfully treated with high-dose intravenous immunoglobulin therapy].
    Kuroda T; Sugimoto A; Ishigaki S; Murakami H; Kawamura M
    Brain Nerve; 2014 Feb; 66(2):185-9. PubMed ID: 24523317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
    Natkunarajah J; Atherton D; Elmslie F; Mansour S; Mortimer P
    Clin Exp Dermatol; 2009 Dec; 34(8):e640-2. PubMed ID: 19549232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent facial erythema with burning sensation and increased temperature: a variant of erythromelalgia or a new entity?
    Luo DQ; Zhao YK; Xu QF; He XQ; Wu LC
    Pain Med; 2014 Jun; 15(6):1007-10. PubMed ID: 24433512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromelalgia with a linear pattern in a 12-year-old girl.
    Huh S; Jung MK; Eun LY; Jung JW; Choi JY
    Pediatr Int; 2015 Aug; 57(4):706-8. PubMed ID: 26315201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive Lumbar Sympathetic Ganglion Block Combined With Epidural Block for Primary Erythromelalgia: A Case Report.
    Ogawa S; Ueno H; Maruyama A; Amaya F
    A A Pract; 2020 Oct; 14(12):e01325. PubMed ID: 33031105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of primary and secondary erythromelalgia.
    Mann N; King T; Murphy R
    Clin Exp Dermatol; 2019 Jul; 44(5):477-482. PubMed ID: 30609105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
    Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E
    Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of erythromelalgia: good response to treatment with gabapentin.
    Ceyhan AM; Gurses I; Yildirim M; Akkaya VB
    J Drugs Dermatol; 2010 May; 9(5):565-7. PubMed ID: 20480803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of primary erythromelalgia improved by mexiletine.
    Jang HS; Jung D; Kim S; Jo J; Lee J; Kim M; Oh C; Kwon K
    Br J Dermatol; 2004 Sep; 151(3):708-10. PubMed ID: 15377366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of familial erythermalgia with the association of lidocaine and mexiletine].
    Legroux-Crespel E; Sassolas B; Guillet G; Kupfer I; Dupre D; Misery L
    Ann Dermatol Venereol; 2003 Apr; 130(4):429-33. PubMed ID: 12843854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.